Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of PET/CT and Therapy Management of Pancreatic Neuroendocrine Tumors
Diletta Calabrò, Giulia Argalia, Valentina Ambrosini
Diagnostics (2020) Vol. 10, Iss. 12, pp. 1059-1059
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

The new WHO classification of gastrointestinal neuroendocrine tumors and immunohistochemical expression of somatostatin receptor 2 and 5
Oana Popa, Sorina Tãban, Stelian Pantea, et al.
Experimental and Therapeutic Medicine (2021) Vol. 22, Iss. 4
Open Access | Times Cited: 57
Peptide Radioligands in Cancer Theranostics: Agonists and Antagonists
Berthold A. Nock, Panagiotis Kanellopoulos, Lieke Joosten, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 5, pp. 674-674
Open Access | Times Cited: 18
Diagnosis, Management and Theragnostic Approach of Gastro-Entero-Pancreatic Neuroendocrine Neoplasms
Leandra Piscopo, Emilia Zampella, Sara Pellegrino, et al.
Cancers (2023) Vol. 15, Iss. 13, pp. 3483-3483
Open Access | Times Cited: 11
Structure and Function of Somatostatin and Its Receptors in Endocrinology
Bo Zhang, Xue Li, Zhe Wu
Endocrine Reviews (2024) Vol. 46, Iss. 1, pp. 26-42
Open Access | Times Cited: 4
Pancreatic neuroendocrine neoplasms — update of the diagnostic and therapeutic guidelines (recommended by the Polish Network of Neuroendocrine Tumours) [Nowotwory neuroendokrynne trzustki — uaktualnione zasady diagnostyki i leczenia (rekomendowane przez Polską Sieć Guzów Neuroendokrynych)]
Beata Kos‐Kudła, Violetta Rosiek, Małgorzata Borowska, et al.
Endokrynologia Polska (2022) Vol. 73, Iss. 3, pp. 491-548
Open Access | Times Cited: 18
Diagnostic Management of Gastroenteropancreatic Neuroendocrine Neoplasms: Technique Optimization and Tips and Tricks for Radiologists
Fabio Pellegrino, Vincenza Granata, Roberta Fusco, et al.
Tomography (2023) Vol. 9, Iss. 1, pp. 217-246
Open Access | Times Cited: 10
Imaging update of pancreatic neuroendocrine neoplasms
Eric Rupe, Mahmoud Diab, LeeAnn Xoubi, et al.
Seminars in Roentgenology (2025) Vol. 60, Iss. 1, pp. 31-43
Closed Access
An endoscopic ultrasound-based interpretable deep learning model and nomogram for distinguishing pancreatic neuroendocrine tumors from pancreatic cancer
Yi Nan, Shuangyang Mo, Yan Zhang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Quantitative 177Lu-DOTATATE SPECT/CT is predictive of 6-month PRRT morphological response in midgut neuroendocrine tumors: a pilot study
Iness Megherbi, Christopher Hoog, Marine Perrier, et al.
EJNMMI Research (2025) Vol. 15, Iss. 1
Open Access
Radioligand therapy in the therapeutic strategy for patients with gastro-entero-pancreatic neuroendocrine tumors: a consensus statement from the Italian Association for Neuroendocrine Tumors (Itanet), Italian Association of Nuclear Medicine (AIMN), Italian Society of Endocrinology (SIE), Italian Association of Medical Oncology (AIOM).
Francesco Panzuto, Manuela Albertelli, Maria Luisa De Rimini, et al.
Journal of Endocrinological Investigation (2024) Vol. 48, Iss. 1, pp. 23-36
Open Access | Times Cited: 3
Changing biological behaviour of NETs during the evolution of the disease: progress on progression
Krystallenia Alexandraki, Ariadni Spyroglou, Stylianos Kykalos, et al.
Endocrine Related Cancer (2021) Vol. 28, Iss. 5, pp. R121-R140
Open Access | Times Cited: 19
Recent developments in the diagnosis of pancreatic neuroendocrine neoplasms
Anna Battistella, Matteo Tacelli, Paola Mapelli, et al.
Expert Review of Gastroenterology & Hepatology (2024) Vol. 18, Iss. 4-5, pp. 155-169
Closed Access | Times Cited: 2
Preoperative prediction of pancreatic neuroendocrine tumor grade based on 68Ga-DOTATATE PET/CT
Jiao Ma, Xiaoyong Wang, Mingsong Tang, et al.
Endocrine (2023) Vol. 83, Iss. 2, pp. 502-510
Open Access | Times Cited: 6
NETest: serial liquid biopsies in gastroenteropancreatic NET surveillance
Mark J C van Treijen, Catharina M. Korse, Wieke H.M. Verbeek, et al.
Endocrine Connections (2022) Vol. 11, Iss. 10
Open Access | Times Cited: 9
Current update on imaging for pancreatic neuroendocrine neoplasms
Nicole Segaran, Catherine Devine, Mindy Wang, et al.
World Journal of Clinical Oncology (2021) Vol. 12, Iss. 10, pp. 897-911
Open Access | Times Cited: 11
Liver Imaging in Gastroenteropancreatic Neuroendocrine Neoplasms
Sunil Jeph, Shiva Gupta, Sireesha Yedururi, et al.
Journal of Computer Assisted Tomography (2024) Vol. 48, Iss. 4, pp. 577-587
Closed Access | Times Cited: 1
National practice patterns in the use of endoscopic ultrasound biopsy for resectable Pancreatic Neuroendocrine Tumors: Insights into the role of DOTATATE PET/CT in diagnosis
Megan Casey, Audrey Brown, Fernanda Romero‐Hernández, et al.
The American Journal of Surgery (2024) Vol. 235, pp. 115779-115779
Open Access | Times Cited: 1
Stereotactic Body Radiation Therapy for Symptomatic Pancreatic Insulinoma: Two-Case Report and Literature Review
A. Namysł-Kaletka, Jerzy Wydmański, Iwona Dębosz-Suwińska, et al.
Current Oncology (2024) Vol. 31, Iss. 7, pp. 4123-4132
Open Access | Times Cited: 1
Characteristics, therapy, and outcome of rare functioning pancreatic neuroendocrine neoplasms
Max B. Albers, Martina Sevcik, Dominik Wiese, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Imaging of neuroendocrine tumors: A pictorial review of the clinical value of different imaging modalities
Ali Pirasteh, Petra Lovrec, Lisa Bodei
Reviews in Endocrine and Metabolic Disorders (2021) Vol. 22, Iss. 3, pp. 539-552
Closed Access | Times Cited: 9
Management of Small Nonfunctioning Pancreatic Neuroendocrine Neoplasms: Current Opinion and Controversies
Woo Hyun Paik, Kyong Joo Lee
Journal of Clinical Medicine (2022) Vol. 12, Iss. 1, pp. 251-251
Open Access | Times Cited: 6
Position Statement on the Diagnosis, Treatment, and Response Evaluation to Systemic Therapies of Advanced Neuroendocrine Tumors, With a Special Focus on Radioligand Therapy
Jaume Capdevila, Enrique Grande, Rocio García‐Carbonero, et al.
The Oncologist (2022) Vol. 27, Iss. 4, pp. e328-e339
Open Access | Times Cited: 5
Advancements of molecular imaging and radiomics in pancreatic carcinoma
Xiaoxi Pang, Liang Xie, Wenjun Yao, et al.
World Journal of Radiology (2023) Vol. 15, Iss. 1, pp. 10-19
Open Access | Times Cited: 2
Case Report: Giant insulinoma, a very rare tumor causing hypoglycemia
Georges Tarris, Alexia Rouland, Kévin Guillen, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 2
Peptide receptor radionuclide therapy as a tool for the treatment of severe hypoglycemia in patients with primary inoperable insulinoma
Marta Opalińska, Anna Sowa‐Staszczak, Ibraheem Al Maraih, et al.
Bio-Algorithms and Med-Systems (2021) Vol. 17, Iss. 4, pp. 221-226
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top